Credicorp Ltd. (0U8N)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 386.51 |
|---|---|
| 52-week range | 221.41 – 423.72 |
| Return, 1 month / 3 months | +1.1% / −0.2% |
| Return, 1 year / 3 years | +54.6% / +261.6% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -15.5% |
| Average daily value traded | 0.16M USD |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Credicorp is a financial services holding company based in Lima, Peru. Through its subsidiaries it provides banking, insurance, pension fund management and microfinance services, mainly to customers in Peru and elsewhere in Latin America. Its banking arm serves individuals and businesses with deposits, loans and payment services, while its insurance and pension businesses offer life and general cover and retirement savings products. The group also lends to small and micro enterprises through a dedicated unit.
Credicorp Ltd. trades under the code 0U8N on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Credicorp Ltd. (0U8N) trades on the London Exchange in UK. It last closed at USD 386.51 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 759 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.6% and over the last three months it fell 0.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.1% | ||
| From 52-week high | -3.9% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.2% | ||
| 6-month return | 25.2% | ||
| 12-month return, skipping the last month | 52.9% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.5% | ||
| Liquidity | 34 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.16M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | +1.1% |
| 3 months | −0.2% |
| 6 months | +25.2% |
| 1 year | +54.6% |
| 3 years | +261.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 380.93 / 347.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | USD 14.4775 |
| 16 May 2025 | USD 10.8399 |
| 23 Sep 2024 | USD 2.9018 |
| 17 May 2024 | USD 9.2677 |
| 18 May 2023 | USD 6.7181 |
| 19 May 2022 | USD 3.9936 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.